Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Enlivex Therapeutics Ltd. (ENLV) Debt to Capital Ratio data is not available for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-2.21M |
|
-- |
|
-- |
|
$2.56M |
|
$-2.56M |
|
$0.35M |
|
$-2.21M |
|
$-2.21M |
|
$-2.21M |
|
$-2.21M |
|
$-2.21M |
|
$-2.21M |
|
$-2.56M |
|
$-2.48M |
|
24.05M |
|
24.05M |
|
$-0.09 |
|
$-0.09 |
|
| Balance Sheet Financials | |
$19.50M |
|
$0.43M |
|
$1.44M |
|
$20.94M |
|
$3.03M |
|
-- |
|
$0.43M |
|
$3.46M |
|
$17.48M |
|
$17.48M |
|
$17.48M |
|
24.29M |
|
| Cash Flow Statement Financials | |
$-7.79M |
|
$8.06M |
|
$0.55M |
|
$3.73M |
|
$4.55M |
|
$0.82M |
|
$0.87M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.43 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.85M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-12.61% |
|
-12.61% |
|
-10.53% |
|
-12.61% |
|
$0.72 |
|
$-0.33 |
|
$-0.32 |
|